Spiro Medical is a medical device company developing a groundbreaking Pulmonary Neuromodulation (PNM) System for asthma treatment.
Spiro Medical has raised $67.0M in total funding. The most recent round was Series A. The last funding was announced in January 2026.
Spiro Medical's investors include HSG, Omega Funds, Andera Partners, Supernova Invest, Northern Light Venture Capital.
Spiro Medical is headquartered in Menlo Park, United States.
Spiro Medical is a medical device company developing a groundbreaking Pulmonary Neuromodulation (PNM) System for asthma treatment.
Spiro Medical is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Spiro Medical — Funding & Investors." VCBacked, January 7, 2026, https://www.vcbacked.co/company/spiro-medical. Accessed July 19, 2026.
VCBacked. (2026). Spiro Medical — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/spiro-medical
{{cite web |title=Spiro Medical — Funding & Investors |url=https://www.vcbacked.co/company/spiro-medical |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated